Can Modern Radiotherapy be used for Extensive Skin Field Cancerisation: An Update on Current Treatment Options

Abstract

The use of Radiotherapy (RT) for skin cancer by dermatologists has decreased since the latter half of last century for many reasons. Driven by clinical need, radiation oncologists, radiation biologists and physicists, have progressed RT in many ways over the course of the last fifty years. The creation of multidisciplinary meetings for clinicians involved in skin cancer has put the specialisties of dermatology and radiation oncology in touch. With better modalities and techniques, is there a new role for RT in skin cancer?. A particular scenario is the treatment of Extensive Skin Field Cancerisation (ESFC), where in situ disease can cause significant symptoms and can lead to invasive disease. Current dermatologic and traditional radiation treatments have been disappointing, especially for large convex surfaces of sun-exposed areas such as scalps. These therapies all suffer from a top down problem. To give enough treatment to fully sterilize in situ disease in deep skin appendages, unacceptable side effects can be suffered in the more superficial layers, sometimes leading to a lack of compliance. This review explains recent advances in RT that allow a more homogenous RT dose through the skin treatment volume. Trials need to be performed with modern RT in ESFC. The review also attempts to set some meaningful definitions that can be used for trials. Hopefully these efforts will lead to better oncological, functional, and cosmetic outcomes for patient suffering from ESFC. Radiotherapy (RT) for skin cancer was a common treatment administered by dermatologists until the 1980s. Better surgical and topical treatments, coupled with increasing radiation regulatory requirements, led to a decline in the use of RT by dermatologists. RT has continued to evolve in the treatment of other cancers. Driven by radiation oncologists, radiation biologists and physicists, RT has progressed in many ways. High quality Randomised Controlled Trials (RCT) has led to an increase in the indications for RT in many tumour types. The creation of multidisciplinary meetings for clinicians involved in skin cancer has put the specialities of dermatology and radiation oncology in touch. This has led to dermatologists asking whether there is a new role for modern RT in the treatment of skin cancer. A particular scenario is the treatment of Extensive Skin Field Cancerisation (ESFC). Patients can suffer with ESFC caused by chronic ultraviolet radiation exposure (Figure 1) Actinic Keratosis (AK), Bowen's disease or Intraepidermal carcinoma (IEC) are found in ESFC from which new invasive Cutaneous Squamous Cell Carcinoma (cSCC) can arise[1]. This disease can cause significant morbidity and poor quality of life, with itch, flaking skin and poor cosmesis. Patients often have comorbidities that preclude other treatments, especially surgery if complex closure is required. Patients may also decline surgery because of fear of a poor functional or cosmetic outcome with the tissue loss that surgery entails. Current dermatologic treatments have been disappointing, especially for larger convex surfaces of sun-exposed areas such as scalps. Recurrence at twelve months is common [2-4]. Not all therapies are readily available. Application can be painful. Skin reaction, sometimes a necessary measure of efficacy, can be unsightly, painful and require significant care including dressings.

Authors and Affiliations

Fogarty GB, David Christie, Lynda J Spelman, Madeleine J Supranowicz, Robert J Sinclair

Keywords

Related Articles

How much salt is sufficient?

Most of the guidelines and textbooks are still recommending hypotonic maintenance fluids for pediatric patients based on Holliday-Segar method. Maintenance intravenous (IV) fluids are designed to maintain homeostasis. Th...

Modification of the Adams Clasps to be Ball Clasps in Clinical Practice Saves Laboratory Time and Makes the Treatment Process of Functional Appliance Smoother

Twin-block appliance (TB) is a powerful appliance to treat the dental and maxillary protrusion in children aged 8-14 years who have transitional dentition. And if the producing process of TB is delayed and/or the childre...

Assessment of Cytotoxic Activity of Calotropis Procera’s Extracts Using Artemia Salina Assay

The essence of the present study is to focus on the cytotoxicity of the aqueous and solvent (acetone, methanol and ethanol) of the medicinal plant (Calotropis procera) belonging to the family Apocynaceae. Brine shrimp le...

Scapula Osteosarcoma

Although conventional osteosarcoma is one of the most common type of primary bone malignancy but fibroblastic subtype is rare enough to push us to report this case. We had experience with scapulectomy for conventional os...

Early Nano Detection of Liver Toxicity and Injury

Nanotechnology increases the biological applications of nanomaterials, especially in the field of nanomedicine. An efficient method for early detection of liver toxicity and prevention of irreversible damage is important...

Download PDF file
  • EP ID EP590797
  • DOI 10.26717/BJSTR.2018.04.000998
  • Views 133
  • Downloads 0

How To Cite

Fogarty GB, David Christie, Lynda J Spelman, Madeleine J Supranowicz, Robert J Sinclair (2018). Can Modern Radiotherapy be used for Extensive Skin Field Cancerisation: An Update on Current Treatment Options. Biomedical Journal of Scientific & Technical Research (BJSTR), 4(1), 3719-3726. https://europub.co.uk/articles/-A-590797